PubMed:10225377
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-141 | Sentence | denotes | Activation of nuclear factor-kappaB by lipopolysaccharide in mononuclear leukocytes is prevented by inhibitors of cytosolic phospholipase A2. |
| T2 | 142-247 | Sentence | denotes | In monocytes, lipopolysaccharide induces synthesis and activity of the 85-kDa cytosolic phospholipase A2. |
| T3 | 248-392 | Sentence | denotes | This enzyme releases arachidonic acid and lyso-phospholipids from membranes which are metabolized to eicosanoids and platelet-activating-factor. |
| T4 | 393-584 | Sentence | denotes | These lipid mediators increase activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation. |
| T5 | 585-823 | Sentence | denotes | We have shown previously that trifluoromethylketone inhibitors of cytosolic phospholipase A2 suppressed interleukin-1beta protein and steady-state mRNA levels in human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes. |
| T6 | 824-943 | Sentence | denotes | In this study, the subcellular mechanisms were analyzed by which trifluoromethylketones interfere with gene expression. |
| T7 | 944-1085 | Sentence | denotes | We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha. |
| T8 | 1086-1200 | Sentence | denotes | Consequently, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were decreased. |
| T9 | 1201-1264 | Sentence | denotes | Trifluoromethylketones ameliorate chronic inflammation in vivo. |
| T10 | 1265-1425 | Sentence | denotes | Thus, this therapeutic potency may reside in retention of inactive nuclear factor-kappaB in the cytosol thereby abrogating interleukin-1beta gene transcription. |
| T1 | 0-141 | Sentence | denotes | Activation of nuclear factor-kappaB by lipopolysaccharide in mononuclear leukocytes is prevented by inhibitors of cytosolic phospholipase A2. |
| T2 | 142-247 | Sentence | denotes | In monocytes, lipopolysaccharide induces synthesis and activity of the 85-kDa cytosolic phospholipase A2. |
| T3 | 248-392 | Sentence | denotes | This enzyme releases arachidonic acid and lyso-phospholipids from membranes which are metabolized to eicosanoids and platelet-activating-factor. |
| T4 | 393-584 | Sentence | denotes | These lipid mediators increase activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation. |
| T5 | 585-823 | Sentence | denotes | We have shown previously that trifluoromethylketone inhibitors of cytosolic phospholipase A2 suppressed interleukin-1beta protein and steady-state mRNA levels in human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes. |
| T6 | 824-943 | Sentence | denotes | In this study, the subcellular mechanisms were analyzed by which trifluoromethylketones interfere with gene expression. |
| T7 | 944-1085 | Sentence | denotes | We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha. |
| T8 | 1086-1200 | Sentence | denotes | Consequently, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were decreased. |
| T9 | 1201-1264 | Sentence | denotes | Trifluoromethylketones ameliorate chronic inflammation in vivo. |
| T10 | 1265-1425 | Sentence | denotes | Thus, this therapeutic potency may reside in retention of inactive nuclear factor-kappaB in the cytosol thereby abrogating interleukin-1beta gene transcription. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-35 | protein | denotes | nuclear factor-kappaB |
| T2 | 61-83 | cell_type | denotes | mononuclear leukocytes |
| T3 | 114-140 | protein | denotes | cytosolic phospholipase A2 |
| T4 | 145-154 | cell_type | denotes | monocytes |
| T5 | 220-246 | protein | denotes | cytosolic phospholipase A2 |
| T6 | 436-457 | protein | denotes | transcription factors |
| T7 | 476-490 | DNA | denotes | cytokine genes |
| T8 | 517-543 | protein | denotes | cytosolic phospholipase A2 |
| T9 | 651-677 | protein | denotes | cytosolic phospholipase A2 |
| T10 | 753-822 | cell_type | denotes | lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes |
| T11 | 983-1005 | RNA | denotes | interleukin-1beta mRNA |
| T12 | 1062-1084 | protein | denotes | inhibitor-kappaB alpha |
| T13 | 1163-1184 | protein | denotes | nuclear factor-kappaB |
| T14 | 1332-1353 | protein | denotes | nuclear factor-kappaB |
| T15 | 1361-1368 | cell_type | denotes | cytosol |
| T16 | 1388-1405 | protein | denotes | interleukin-1beta |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-141 | Sentence | denotes | Activation of nuclear factor-kappaB by lipopolysaccharide in mononuclear leukocytes is prevented by inhibitors of cytosolic phospholipase A2. |
| S2 | 142-247 | Sentence | denotes | In monocytes, lipopolysaccharide induces synthesis and activity of the 85-kDa cytosolic phospholipase A2. |
| S3 | 248-392 | Sentence | denotes | This enzyme releases arachidonic acid and lyso-phospholipids from membranes which are metabolized to eicosanoids and platelet-activating-factor. |
| S4 | 393-584 | Sentence | denotes | These lipid mediators increase activity of transcription factors and expression of cytokine genes indicating a function for cytosolic phospholipase A2 in signal transduction and inflammation. |
| S5 | 585-823 | Sentence | denotes | We have shown previously that trifluoromethylketone inhibitors of cytosolic phospholipase A2 suppressed interleukin-1beta protein and steady-state mRNA levels in human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes. |
| S6 | 824-943 | Sentence | denotes | In this study, the subcellular mechanisms were analyzed by which trifluoromethylketones interfere with gene expression. |
| S7 | 944-1085 | Sentence | denotes | We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha. |
| S8 | 1086-1200 | Sentence | denotes | Consequently, cytosolic activation, nuclear translocation and DNA-binding of nuclear factor-kappaB were decreased. |
| S9 | 1201-1264 | Sentence | denotes | Trifluoromethylketones ameliorate chronic inflammation in vivo. |
| S10 | 1265-1425 | Sentence | denotes | Thus, this therapeutic potency may reside in retention of inactive nuclear factor-kappaB in the cytosol thereby abrogating interleukin-1beta gene transcription. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 14-35 | NP | denotes | nuclear factor-kappaB |
| C2 | 114-140 | NP | denotes | cytosolic phospholipase A2 |
| C3 | 213-246 | NP | denotes | 85-kDa cytosolic phospholipase A2 |
| C4 | 248-259 | NP | denotes | This enzyme |
| C6 | 314-323 | NP | denotes | membranes |
| C7 | 324-329 | NP | denotes | which |
| C5 | 269-391 | NP | denotes | arachidonic acid and lyso-phospholipids from membranes which are metabolized to eicosanoids and platelet-activating-factor |
| C8 | 393-414 | NP | denotes | These lipid mediators |
| C9 | 517-543 | NP | denotes | cytosolic phospholipase A2 |
| C10 | 651-677 | NP | denotes | cytosolic phospholipase A2 |
| C11 | 839-865 | NP | denotes | the subcellular mechanisms |
| C12 | 883-888 | NP | denotes | which |
| C13 | 889-911 | NP | denotes | trifluoromethylketones |
| C14 | 958-962 | NP | denotes | they |
| C15 | 1163-1184 | NP | denotes | nuclear factor-kappaB |
| C16 | 1201-1223 | NP | denotes | Trifluoromethylketones |
| R1 | C3 | C2 | coref-ident | 85-kDa cytosolic phospholipase A2,cytosolic phospholipase A2 |
| R2 | C4 | C3 | coref-ident | This enzyme,85-kDa cytosolic phospholipase A2 |
| R3 | C7 | C6 | coref-relat | which,membranes |
| R4 | C8 | C5 | coref-ident | These lipid mediators,arachidonic acid and lyso-phospholipids from membranes which are metabolized to eicosanoids and platelet-activating-factor |
| R5 | C9 | C4 | coref-ident | cytosolic phospholipase A2,This enzyme |
| R6 | C10 | C9 | coref-ident | cytosolic phospholipase A2,cytosolic phospholipase A2 |
| R7 | C12 | C11 | coref-relat | which,the subcellular mechanisms |
| R8 | C14 | C13 | coref-pron | they,trifluoromethylketones |
| R9 | C15 | C1 | coref-ident | nuclear factor-kappaB,nuclear factor-kappaB |
| R10 | C16 | C13 | coref-ident | Trifluoromethylketones,trifluoromethylketones |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-35 | protein_complex | denotes | nuclear factor-kappaB |
| T2 | 39-57 | lipid | denotes | lipopolysaccharide |
| T3 | 61-83 | cell_type | denotes | mononuclear leukocytes |
| T4 | 114-140 | protein_molecule | denotes | cytosolic phospholipase A2 |
| T5 | 145-154 | cell_type | denotes | monocytes |
| T6 | 156-174 | lipid | denotes | lipopolysaccharide |
| T7 | 220-246 | protein_molecule | denotes | cytosolic phospholipase A2 |
| T8 | 269-285 | other_organic_compound | denotes | arachidonic acid |
| T9 | 290-308 | lipid | denotes | lyso-phospholipids |
| T10 | 349-360 | other_organic_compound | denotes | eicosanoids |
| T11 | 365-391 | other_organic_compound | denotes | platelet-activating-factor |
| T12 | 436-457 | protein_family_or_group | denotes | transcription factors |
| T13 | 476-490 | DNA_family_or_group | denotes | cytokine genes |
| T14 | 517-543 | protein_molecule | denotes | cytosolic phospholipase A2 |
| T15 | 547-566 | other_name | denotes | signal transduction |
| T16 | 571-583 | other_name | denotes | inflammation |
| T17 | 615-647 | other_organic_compound | denotes | trifluoromethylketone inhibitors |
| T18 | 651-677 | protein_molecule | denotes | cytosolic phospholipase A2 |
| T19 | 719-743 | other_name | denotes | steady-state mRNA levels |
| T20 | 753-771 | lipid | denotes | lipopolysaccharide |
| T21 | 800-822 | cell_type | denotes | mononuclear leukocytes |
| T22 | 843-865 | other_name | denotes | subcellular mechanisms |
| T23 | 889-911 | other_organic_compound | denotes | trifluoromethylketones |
| T24 | 927-942 | other_organic_compound | denotes | gene expression |
| T25 | 983-1005 | RNA_family_or_group | denotes | interleukin-1beta mRNA |
| T26 | 1062-1084 | protein_molecule | denotes | inhibitor-kappaB alpha |
| T27 | 1100-1120 | other_name | denotes | cytosolic activation |
| T28 | 1122-1143 | other_name | denotes | nuclear translocation |
| T29 | 1163-1184 | protein_complex | denotes | nuclear factor-kappaB |
| T30 | 1201-1223 | other_organic_compound | denotes | Trifluoromethylketones |
| T31 | 1235-1242 | other_name | denotes | chronic |
| T32 | 1243-1255 | other_name | denotes | inflammation |
| T33 | 1332-1353 | protein_complex | denotes | nuclear factor-kappaB |
| T34 | 1361-1368 | cell_type | denotes | cytosol |
| T35 | 1388-1405 | protein_molecule | denotes | interleukin-1beta |